| scholarly article | Q13442814 |
| P50 | author | Cristina Cigana | Q56223988 |
| Nicola Ivan Lorè | Q57630158 | ||
| Annamaria Naggi | Q59387864 | ||
| P2093 | author name string | Alessandra Bragonzi | |
| Camilla Riva | |||
| Ida De Fino | |||
| Barbara Sipione | |||
| Lorenza Spagnuolo | |||
| Noemi Veraldi | |||
| Medede Melessike | |||
| Elisa Calzi | |||
| P2860 | cites work | The heparan sulfate binding sequence of interferon-gamma increased the on rate of the interferon-gamma-interferon-gamma receptor complex formation | Q28268586 |
| Pseudomonas aeruginosa exploits lipid A and muropeptides modification as a strategy to lower innate immunity during cystic fibrosis lung infection | Q28472320 | ||
| Molecular weight determination of heparin and dermatan sulfate by size exclusion chromatography with a triple detector array | Q31139647 | ||
| BIIL 284 reduces neutrophil numbers but increases P. aeruginosa bacteremia and inflammation in mouse lungs | Q34180324 | ||
| Nonmucoid Pseudomonas aeruginosa expresses alginate in the lungs of patients with cystic fibrosis and in a mouse model. | Q34232085 | ||
| Cystic fibrosis-niche adaptation of Pseudomonas aeruginosa reduces virulence in multiple infection hosts | Q34256578 | ||
| Examination of the substrate specificity of heparin and heparan sulfate lyases | Q34324156 | ||
| IL-17A impairs host tolerance during airway chronic infection by Pseudomonas aeruginosa | Q34527023 | ||
| Glycosaminoglycan binding and oligomerization are essential for the in vivo activity of certain chemokines | Q34762409 | ||
| Adaptation of Pseudomonas aeruginosa in Cystic Fibrosis airways influences virulence of Staphylococcus aureus in vitro and murine models of co-infection | Q35113179 | ||
| Host genetic background influences the response to the opportunistic Pseudomonas aeruginosa infection altering cell-mediated immunity and bacterial replication | Q35288221 | ||
| Heparin derivatives for the targeting of multiple activities in the inflammatory response. | Q51025748 | ||
| The catalytic machinery of chondroitinase ABC I utilizes a calcium coordination strategy to optimally process dermatan sulfate. | Q51134862 | ||
| Assessing Pseudomonas aeruginosa virulence and the host response using murine models of acute and chronic lung infection. | Q51724332 | ||
| The involvement of glycosaminoglycans in airway disease associated with cystic fibrosis. | Q53252194 | ||
| Pseudomonas aeruginosaMicroevolution during Cystic Fibrosis Lung Infection Establishes Clones with Adapted Virulence | Q61477540 | ||
| Host genetic diversity influences the severity of Pseudomonas aeruginosa pneumonia in the Collaborative Cross mice | Q35756714 | ||
| Host-pathogen interplay in the respiratory environment of cystic fibrosis | Q35799736 | ||
| Pseudomonas aeruginosa pili and flagella mediate distinct binding and signaling events at the apical and basolateral surface of airway epithelium | Q35873580 | ||
| The syndecan-1 heparan sulfate proteoglycan is a viable target for myeloma therapy | Q35990705 | ||
| Cystic fibrosis: a mucosal immunodeficiency syndrome. | Q36623329 | ||
| The 'sweet' and 'bitter' involvement of glycosaminoglycans in lung diseases: pharmacotherapeutic relevance | Q37346515 | ||
| Glycol-split nonanticoagulant heparins are inhibitors of hepcidin expression in vitro and in vivo. | Q37623543 | ||
| Heparin-derived heparan sulfate mimics to modulate heparan sulfate-protein interaction in inflammation and cancer | Q37736668 | ||
| Chronic obstructive pulmonary disease (COPD): evaluation from clinical, immunological and bacterial pathogenesis perspectives | Q38192501 | ||
| The Pseudomonas aeruginosa PAO1 Two-Component Regulator CarSR Regulates Calcium Homeostasis and Calcium-Induced Virulence Factor Production through Its Regulatory Targets CarO and CarP. | Q38294389 | ||
| New insights into the inhibition of human neutrophil elastase by heparin | Q38311212 | ||
| Structural studies on the bacterial lyase-resistant tetrasaccharides derived from the antithrombin III-binding site of porcine intestinal heparin | Q38321013 | ||
| Defining the interleukin-8-binding domain of heparan sulfate | Q38336349 | ||
| Tracking the immunopathological response to Pseudomonas aeruginosa during respiratory infections. | Q38522938 | ||
| The Role of Neutrophil Elastase Inhibitors in Lung Diseases | Q38690959 | ||
| The clinical impact of major comorbidities on idiopathic pulmonary fibrosis | Q38748617 | ||
| Antitumor efficacy of the heparanase inhibitor SST0001 alone and in combination with antiangiogenic agents in the treatment of human pediatric sarcoma models. | Q39184529 | ||
| The host genetic background defines diverse immune-reactivity and susceptibility to chronic Pseudomonas aeruginosa respiratory infection | Q40450037 | ||
| The IL-17A/IL-17RA axis in pulmonary defence and immunopathology | Q40733585 | ||
| Role of heparan sulphate proteoglycans as potential receptors for non-piliated Pseudomonas aeruginosa adherence to non-polarised airway epithelial cells. | Q40824581 | ||
| Acute Exacerbations of COPD Are Associated With Increased Expression of Heparan Sulfate and Chondroitin Sulfate in BAL. | Q41081198 | ||
| Dampening Host Sensing and Avoiding Recognition in Pseudomonas aeruginosa Pneumonia. | Q42043676 | ||
| Heparin and heparan sulphate are inhibitors of human leucocyte elastase | Q43768379 | ||
| Sputum sol neutrophil elastase activity in bronchiectasis: differential modulation by syndecan-1. | Q44408401 | ||
| Undersulfated and glycol-split heparins endowed with antiangiogenic activity | Q44754685 | ||
| Modulation of the heparanase-inhibiting activity of heparin through selective desulfation, graded N-acetylation, and glycol splitting | Q45221614 | ||
| Endothelial activation and increased heparan sulfate expression in cystic fibrosis | Q47774987 | ||
| Increased deposition of glycosaminoglycans and altered structure of heparan sulfate in idiopathic pulmonary fibrosis | Q48019677 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Pseudomonas aeruginosa | Q31856 |
| P577 | publication date | 2018-01-09 | |
| P1433 | published in | International Journal of Molecular Sciences | Q3153277 |
| P1476 | title | Synthesized Heparan Sulfate Competitors Attenuate Pseudomonas aeruginosa Lung Infection | |
| P478 | volume | 19 |
Search more.